Kyntra BIO, Inc (KYNB) insider trading

Every open-market stock purchase and sale by Kyntra BIO, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • No open-market insider trades in the last 12 months.
  • Last insider buy: Thane Wettig (CEO), $19.9K, 5 months ago.

Last 12 months: insiders bought $39.7K (2 buys) and sold $0 (0 sales). Last close $7.97 on Sep 11, 2026.

Recent KYNB insider trades

DateInsiderTradeValue
Sep 6, 2026Thane Wettig (CEO)Sold (not open market)$1.8K
Sep 6, 2026David DeLucia (CFO)Sold (not open market)$188
Jun 12, 2026Michael Kauffman (Insider)Bought (not open market)—
Jun 12, 2026Maykin Ho (Insider)Bought (not open market)—
Jun 12, 2026James A Schoeneck (Insider)Bought (not open market)—
Jun 12, 2026Jeffrey L Edwards (Insider)Bought (not open market)—
Jun 6, 2026Thane Wettig (CEO)Sold (not open market)$1.3K
Jun 6, 2026David DeLucia (CFO)Sold (not open market)$349
May 14, 2026Thane Wettig (CEO)Bought$19.9K
May 14, 2026Thane Wettig (CEO)Bought$19.9K
Mar 6, 2026Thane Wettig (CEO)Sold (not open market)$1.9K
Mar 6, 2026David DeLucia (CFO)Sold (not open market)$410
Feb 3, 2026Thane Wettig (CEO)Bought (not open market)—
Feb 3, 2026David DeLucia (CFO)Bought (not open market)—

Who's trading KYNB

Get free alerts when an insider at Kyntra BIO, Inc files a new trade →